There are a number of errors in the “aOR (95%CI)” columns for Tables 3 and 4. During secondary analysis, the authors observed 128 duplicate entries in the study database among 4054 included in the analyses. Despite observing the random distribution of duplicates, the authors performed all analyses again after removal of the 128 duplicates (leaving 3926 patients in the analyses) and found negligible effect on the outcome measures: aOR for arm associated with unfavourable outcome now 0.93 (0.80–1.09) compared to 0.93 (0.79–1.08) in the original article; while aOR for TB-attributed deaths is 0.69 (0.46–1.04) compared to 0.65 (0.44–0.97). Even though the 95% confidence interval of the aOR for TB attributed death now includes 1, the difference with the originally reported aOR and the width of its confidence interval are minimal, hence the conclusions from the results remain unchanged. Please see the correct Tables 3 and 4 here.
Citation: Trajman A, Durovni B, Saraceni V, Menezes A, Cordeiro-Santos M, Cobelens F, et al. (2016) Correction: Impact on Patients' Treatment Outcomes of XpertMTB/RIF Implementation for the Diagnosis of Tuberculosis: Follow-Up of a Stepped-Wedge Randomized Clinical Trial. PLoS ONE11(5): e0156471. https://doi.org/10.1371/journal.pone.0156471
Published: May 24, 2016
Copyright: © 2016 Trajman et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.